MNOV
Price:
$2.12
Market Cap:
$103.98M
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction. Its product pipeline also includes MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of ...[Read more]
Industry
Biotechnology
IPO Date
2006-12-08
Stock Exchange
NASDAQ
Ticker
MNOV
According to MediciNova, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 61.90M. This represents a change of 82.04% compared to the average of 34.00M of the last 4 quarters.
The mean historical Enterprise Value of MediciNova, Inc. over the last ten years is 140.64M. The current 61.90M Enterprise Value has changed 4.30% with respect to the historical average. Over the past ten years (40 quarters), MNOV's Enterprise Value was at its highest in in the September 2018 quarter at 474.87M. The Enterprise Value was at its lowest in in the December 2023 quarter at 22.79M.
Average
140.64M
Median
129.36M
Minimum
22.79M
Maximum
300.89M
Discovering the peaks and valleys of MediciNova, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 113.46%
Maximum Annual Enterprise Value = 300.89M
Minimum Annual Increase = -72.28%
Minimum Annual Enterprise Value = 22.79M
Year | Enterprise Value | Change |
---|---|---|
2023 | 22.79M | -72.28% |
2022 | 82.19M | 39.46% |
2021 | 58.94M | -66.08% |
2020 | 173.76M | -23.62% |
2019 | 227.50M | -24.39% |
2018 | 300.89M | 50.94% |
2017 | 199.34M | 13.42% |
2016 | 175.76M | 106.88% |
2015 | 84.96M | 5.87% |
2014 | 80.24M | 113.46% |
The current Enterprise Value of MediciNova, Inc. (MNOV) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
54.64M
5-year avg
113.04M
10-year avg
140.64M
MediciNova, Inc.’s Enterprise Value is greater than Aerovate Therapeutics, Inc. (43.34M), greater than Adagene Inc. (8.35M), less than Acrivon Therapeutics, Inc. Common Stock (158.62M), less than Rezolute, Inc. (248.88M), greater than AN2 Therapeutics, Inc. (8.33M), less than Eliem Therapeutics, Inc. (0), less than Molecular Partners AG (0), less than Champions Oncology, Inc. (107.67M), less than Cyteir Therapeutics, Inc. (116.09M), greater than Anebulo Pharmaceuticals, Inc. (-20511738.00), greater than PMV Pharmaceuticals, Inc. (31.01M), greater than Pharvaris N.V. (42.60M), less than PepGen Inc. (678.47M), less than null (103.55M),
Company | Enterprise Value | Market cap |
---|---|---|
43.34M | $73.92M | |
8.35M | $83.23M | |
158.62M | $198.03M | |
248.88M | $257.27M | |
8.33M | $41.83M | |
0 | $342.68M | |
0 | $200.54M | |
107.67M | $112.07M | |
116.09M | $108.71M | |
-20511738.00 | $32.42M | |
31.01M | $78.14M | |
42.60M | $1.02B | |
678.47M | $126.80M | |
103.55M | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MediciNova, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MediciNova, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is MediciNova, Inc.'s Enterprise Value?
What is the highest Enterprise Value for MediciNova, Inc. (MNOV)?
What is the 3-year average Enterprise Value for MediciNova, Inc. (MNOV)?
What is the 5-year average Enterprise Value for MediciNova, Inc. (MNOV)?
How does the current Enterprise Value for MediciNova, Inc. (MNOV) compare to its historical average?